BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36285529)

  • 1. Performance of SCORE2 and SCORE2-OP risk algorithms in a Cypriot cohort.
    Nicolaides AN; Griffin M; Panayiotou AG; Tyllis T; Bond D; Georgiou N; Kyriacou E; Avraamides C; Martin RM
    Int Angiol; 2022 Dec; 41(6):492-499. PubMed ID: 36285529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of Systematic Coronary Risk Evaluation 2 (SCORE2) and SCORE2-Older Persons in the EPIC-Norfolk prospective population cohort.
    van Trier TJ; Snaterse M; Boekholdt SM; Scholte Op Reimer WJM; Hageman SHJ; Visseren FLJ; Dorresteijn JAN; Peters RJG; Jørstad HT
    Eur J Prev Cardiol; 2024 Jan; 31(2):182-189. PubMed ID: 37793098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the European SCORE2 models in a Canadian primary care cohort.
    Sud M; Sivaswamy A; Austin PC; Abdel-Qadir H; Anderson TJ; Khera R; Naimark DMJ; Lee DS; Roifman I; Thanassoulis G; Tu K; Wijeysundera HC; Ko DT
    Eur J Prev Cardiol; 2024 Apr; 31(6):668-676. PubMed ID: 37946603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.
    SCORE2-OP working group and ESC Cardiovascular risk collaboration
    Eur Heart J; 2021 Jul; 42(25):2455-2467. PubMed ID: 34120185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiovascular risk assessment among patients with hypertension based on SCORE2 and SCORE-OP algorithms in black Africans].
    Yao H; Ekou A; Ehouman E; Guezo M; Soya E; Kouadio D; Touré C; Kipenge R; Koffi D; N'Guetta R
    Ann Cardiol Angeiol (Paris); 2023 Jun; 72(3):101602. PubMed ID: 37187110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2.
    Hageman SHJ; Petitjaen C; Pennells L; Kaptoge S; Pajouheshnia R; Tillmann T; Blaha MJ; McClelland RL; Matsushita K; Nambi V; Klungel OH; Souverein PC; van der Schouw YT; Verschuren WMM; Lehmann N; Erbel R; Jöckel KH; Di Angelantonio E; Visseren FLJ; Dorresteijn JAN
    Eur J Prev Cardiol; 2023 Oct; 30(15):1705-1714. PubMed ID: 37264679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of carotid plaque imaging using total plaque area added to SCORE2 in middle-aged subjects: the ARteris Cardiovascular Outcome (ARCO) cohort study.
    Romanens M; Adams A; Wenger M; Warmuth W; Sudano I
    Swiss Med Wkly; 2024 Jan; 154():3735. PubMed ID: 38579303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining European and U.S. risk prediction models with polygenic risk scores to refine cardiovascular prevention: the CoLaus|PsyCoLaus Study.
    de La Harpe R; Thorball CW; Redin C; Fournier S; Müller O; Strambo D; Michel P; Vollenweider P; Marques-Vidal P; Fellay J; Vaucher J
    Eur J Prev Cardiol; 2023 May; 30(7):561-571. PubMed ID: 36652418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the SCORE2 risk prediction algorithm in a Portuguese population: A new model to estimate 10-year cardiovascular disease incidence in Europe.
    Temtem M; Mendonça MI; Santos M; Sá D; Sousa F; Freitas S; Borges S; Henriques E; Rodrigues M; Soares C; Rodrigues R; Serrão M; Drumond A; Sousa AC; Palma Reis R
    Rev Port Cardiol; 2024 Feb; ():. PubMed ID: 38395299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison and Optimization of Cardiovascular Risk Scores in Predicting the 4-Year Outcome of Patients with Obstructive Coronary Arteries Disease.
    Qiu T; Liang C; Ming B; Liu G; Zhang F; Zeng R; Xie D; Zou Q
    Ther Clin Risk Manag; 2023; 19():319-328. PubMed ID: 37038594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm.
    Hageman SHJ; McKay AJ; Ueda P; Gunn LH; Jernberg T; Hagström E; Bhatt DL; Steg PG; Läll K; Mägi R; Gynnild MN; Ellekjær H; Saltvedt I; Tuñón J; Mahíllo I; Aceña Á; Kaminski K; Chlabicz M; Sawicka E; Tillman T; McEvoy JW; Di Angelantonio E; Graham I; De Bacquer D; Ray KK; Dorresteijn JAN; Visseren FLJ
    Eur Heart J; 2022 May; 43(18):1715-1727. PubMed ID: 35165703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up.
    Polo Y la Borda J; Castañeda S; Sánchez-Alonso F; Plaza Z; García-Gómez C; Ferraz-Amaro I; Erausquin C; Valls-García R; Fábregas MD; Delgado-Frías E; Mas AJ; González-Juanatey C; Llorca J; González-Gay MA;
    Semin Arthritis Rheum; 2024 Jun; 66():152442. PubMed ID: 38555727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Risk Assessment and Control in Outpatients Evaluated by 24-hour Ambulatory Blood Pressure and Different LDL-C Equations.
    Landolfo M; Allevi M; Spannella F; Giulietti F; Gezzi A; Sarzani R
    High Blood Press Cardiovasc Prev; 2023 Nov; 30(6):551-560. PubMed ID: 37902917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCORE and SCORE2 in East Asian Population: A Performance Comparison.
    Choi J; Sung S; Park SK; Park S; Kim H; Cho MC; Williams B; Lee HY
    JACC Asia; 2024 Apr; 4(4):265-274. PubMed ID: 38660103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carotid Plaque Score for Stroke and Cardiovascular Risk Prediction in a Middle-Aged Cohort From the General Population.
    Ihle-Hansen H; Vigen T; Berge T; Walle-Hansen MM; Hagberg G; Ihle-Hansen H; Thommessen B; Ariansen I; Røsjø H; Rønning OM; Tveit A; Lyngbakken M
    J Am Heart Assoc; 2023 Sep; 12(17):e030739. PubMed ID: 37609981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carotid ultrasound and systematic coronary risk assessment 2 in the prediction of cardiovascular events.
    Bao X; Xu B; Lind L; Engström G
    Eur J Prev Cardiol; 2023 Aug; 30(10):1007-1014. PubMed ID: 37159540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac status and atherosclerotic cardiovascular risk of convalescents after COVID-19 in Poland.
    Łoboda D; Sarecka-Hujar B; Wilczek J; Gibiński M; Zielińska-Danch W; Szołtysek-Bołdys I; Paradowska-Nowakowska E; Nowacka-Chmielewska M; Grabowski M; Lejawa M; Małecki A; Gołba KS
    Pol Arch Intern Med; 2023 Aug; 133(7-8):. PubMed ID: 36861463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial analysis of 10-year predicted risk and incident atherosclerotic cardiovascular disease: the CoLaus cohort.
    Jordan G; Ridder D; Joost S; Vollenweider P; Preisig M; Marques-Vidal P; Guessous I; Vaucher J
    Sci Rep; 2024 Feb; 14(1):4752. PubMed ID: 38413661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe.
    SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration
    Eur Heart J; 2023 Jul; 44(28):2544-2556. PubMed ID: 37247330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum uric acid significantly improves the accuracy of cardiovascular risk score models.
    Moshkovits Y; Tiosano S; Kaplan A; Kalstein M; Bayshtok G; Kivity S; Segev S; Grossman E; Segev A; Maor E; Fardman A
    Eur J Prev Cardiol; 2023 May; 30(7):524-532. PubMed ID: 36378558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.